Drugmaker GlaxoSmithKline , which was fined a record 3 billion yuan ($483 million) for corruption in China last year and is examining possible staff misconduct elsewhere, faces new allegations of bribery in Romania. (financialexpress.com)
from Pocket http://ift.tt/1KKePQK
Aucun commentaire:
Enregistrer un commentaire